Suppr超能文献

[现代外科技术治疗慢性直肠周炎患者]

[Modern surgical technologies in the treatment of patients with chronic paraproctitis].

作者信息

Kotenko K V, Kovalev S A, Bedzhanyan A L, Khitaryan A G, Alibekov A Z, Mikhailova A A, Korchazhkina N B

机构信息

Petrovsky National Research Centre of Surgery, Moscow, Russia.

Rostov State Medical University, Rostov-on-Don, Russia.

出版信息

Khirurgiia (Mosk). 2022(4):80-85. doi: 10.17116/hirurgia202204180.

Abstract

UNLABELLED

The development of minimally invasive surgical technologies in the treatment of chronic paraproctitis is a promising young trend in coloproctology. Increasingly, in clinical practice, coloproctologists use laser technologies in the outpatient treatment of extra- and transsphincteric pararectal fistulas, in particular, laser technology FiLaC (Fistula Laser Closure).

OBJECTIVE

Conducting a comparative retrospective and prospective cohort study of immediate and long-term results of treatment of complicated transsphincteric and extrasphincteric fistulas using the developed modified FiLaC technology with the «traditional» FiLaC technology, and standard excision of the fistulous tract with plasty of the internal fistula opening with a full-thickness flap of the rectal wall.

MATERIAL AND METHODS

The study included 270 patients with trans- and extrasphincter pararectal fistulas, which were divided into three groups. In group 1 (=90) the traditional FiLaC technology was used for the treatment of fistulas, in group 2 (=90) the modified FiLaC technology was used, providing for the opening of purulent streaks and laser coagulation (FiLaC) of the intrasphincter part of the fistula with a Biolitec laser, 12 W, 100 J/cm, in group 3 (=90), excision of the fistula tract with plastic surgery of the internal fistula opening with a full-thickness flap of the rectal wall was used.

RESULTS

The results of treatment in patients of the three groups were monitored for 19-36 months. after surgery (median 31 months). The analysis of the results showed that in group 2 (modified FiLaC technology) healing of fistulas occurred faster (7.3±0.5 weeks versus 12.6±0.7 weeks) compared to group 3 (excision of the fistula with plasty of the internal fistula opening). The indicators of sphincterometry in the long-term period in patients of the 2nd group were restored in relation to the initial ones, and in the th group 3 they were reduced compared to the initial values. Postoperative complications were most common in patients of group 3 (32.2%), and least often in patients of group 2 - 8.9%. At the same time, late postoperative complications were most common (24.4%) in patients of group 1. None of the patients in group 2 had late postoperative complications, while 11.1% of postoperative complications were recorded in group 3. In patients who underwent excision of the AC (group 3), relapses were most common: early - 15.6%, late - in 21.1%. The least frequent relapses were observed in patients who underwent modified FiLaC technology (Group 2): 6.7% - early relapses and 11.1% - late relapses.

CONCLUSION

The use of the modified FiLaC technology in the treatment of trans- and extrasphincteric fistulas of the rectum made it possible to minimize postoperative complications, fully preserve the function of anal holding, and achieve healing of fistulas in 82.5% of cases with a median follow-up of 31 months.

摘要

未标注

微创外科技术在慢性直肠周围炎治疗中的发展是结直肠外科学中一个有前景的新兴趋势。在临床实践中,结直肠外科医生越来越多地在门诊治疗直肠旁外括约肌和经括约肌瘘时使用激光技术,特别是激光技术FiLaC(瘘管激光闭合术)。

目的

采用改良的FiLaC技术与“传统”FiLaC技术以及瘘管标准切除并直肠壁全层皮瓣修补内瘘口术,对复杂性经括约肌和直肠旁外括约肌瘘的近期和长期治疗结果进行比较回顾性和前瞻性队列研究。

材料与方法

该研究纳入270例直肠旁经括约肌和直肠旁外括约肌瘘患者,分为三组。第1组(=90例)采用传统FiLaC技术治疗瘘管,第2组(=90例)采用改良FiLaC技术,即使用Biolitec激光(12W,100J/cm)打开脓性条索并对瘘管的括约肌内部分进行激光凝固(FiLaC),第3组(=90例)采用瘘管切除并直肠壁全层皮瓣修补内瘘口术。

结果

对三组患者术后19 - 36个月(中位时间31个月)的治疗结果进行监测。结果分析表明,与第3组(瘘管切除并修补内瘘口)相比(12.6±0.7周),第2组(改良FiLaC技术)瘘管愈合更快(7.3±0.5周)。第2组患者长期括约肌测量指标恢复至初始水平,而第3组与初始值相比有所降低。术后并发症在第3组患者中最为常见(32.2%),在第2组患者中最少见 - 8.9%。同时,术后晚期并发症在第1组患者中最为常见(24.4%)。第2组患者无术后晚期并发症,而第3组记录到11.1% 的术后并发症。在接受瘘管切除的患者(第3组)中复发最为常见:早期 - 15.6%,晚期 - 21.1%。在接受改良FiLaC技术的患者(第2组)中观察到的复发最少:早期复发6.7%,晚期复发11.1%。

结论

在直肠经括约肌和直肠旁外括约肌瘘的治疗中使用改良FiLaC技术可将术后并发症降至最低,充分保留肛门控便功能,在中位随访31个月时82.5% 的病例实现瘘管愈合。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验